Stockreport

NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF for severe neurodegenerative diseases, announces that it has received a notice of delisting from Nasdaq. The staff of the Listing Qualifications Department has determi [Read more]